| ★ | Why Early GPP Treatment is Critical | | 6 | Estados Unidos | |
| 10 | Navigating Comorbidities in Pediatric Atopic Dermatitis | | 24 | Estados Unidos | 100 |
| 7 | A New Era of Generalized Pustular Psoriasis Care | | 14 | Estados Unidos | 100 |
| 3 | Targeting Drivers of Itch in Atopic Dermatitis | | 12 | Estados Unidos | 100 |
| 6 | The Future of Personalized Atopic Dermatitis Care | | 12 | Estados Unidos | 100 |
| 11 | A New Standard for Success in Atopic Dermatitis Treatment | | 12 | Estados Unidos | 100 |
| 5 | Moving GPP Care Forward: From Awareness to Action | | 7 | Estados Unidos | 100 |
| 15 | GPP vs. Plaque Psoriasis: Differentiation and Treatment Considerations | | 7 | Estados Unidos | 100 |
| 20 | Improving Recognition and Diagnosis of GPP | | 7 | Estados Unidos | 100 |
| 13 | Allergic Comorbidities in Atopic Dermatitis: What the Evidence Shows | | 6 | Estados Unidos | 100 |
| 14 | Why Earlier Treatment Matters in Moderate-to-Severe Atopic Dermatitis | | 6 | Estados Unidos | 100 |
| 16 | Understanding IL-36 Signaling in GPP and Related Neutrophilic Dermatoses | | 6 | Estados Unidos | 100 |
| 8 | The Inflammatory Drivers of Itch in Atopic Dermatitis | | 4 | Estados Unidos | 100 |
| 2 | Recognizing and Managing Acute GPP Flares | | 3 | Estados Unidos | 100 |
| 12 | Defining Treatment Success in GPP | | 3 | Estados Unidos | 100 |
| 18 | Evolving Safety Considerations in Atopic Dermatitis Management | | 3 | Estados Unidos | 100 |
| 1 | A Personalized Approach to GPP Care | | 2 | Estados Unidos | 100 |
| 4 | The Full Picture: Assessing Psoriasis Severity | | 2 | Estados Unidos | 100 |
| 9 | Overcoming Barriers to Successful Psoriasis Treatment | | 2 | Estados Unidos | 100 |
| 17 | Identifying GPP: Clinical Clues Across Phases | | 2 | Estados Unidos | 100 |
| 19 | AAD Guidance on Moisturization for Atopic Dermatitis Prevention | | 1 | Estados Unidos | 100 |